Biotechnology

If regular biology is understanding nature, biotechnology is hacking it. We're talking transgenic animals (pigs with human genes), gene therapy (fixing broken DNA), RNA interference (silencing bad genes), molecular diagnostics, and the ethical firestorm around all of it. This is biology's wild side. Transgenic animals have foreign genes deliberately inserted into their genome. They're created by microinjecting the foreign gene into a fertilized egg, then implanting it into a surrogate mother. The resulting animal expresses the foreign gene. Why do this? For several reasons. Rosie, a transgenic cow, produced human alpha-lactalbumin in her milk — making the milk more nutritious for human infants. Transgenic mice carrying human genes are used to study human diseases (cancer, Alzheimer's, diabetes) because you can't experiment on humans. Some transgenic goats produce spider silk protein in their milk — a material stronger than steel but flexible. Others produce human therapeutic proteins (antithrombin, factor IX for hemophilia) in their milk. Gene therapy aims to fix genetic disorders by delivering a working copy of the defective gene. In ex vivo gene therapy, cells are removed from the patient, genetically modified in the lab, and returned. In in vivo therapy, the therapeutic gene is delivered directly into the patient's body. The delivery vehicle is usually a modified virus (retrovirus, adenovirus, AAV) that has been engineered to be safe. The first success was for SCID (severe combined immunodeficiency) — bubble boy disease, where children lack a functional immune system. In 1990, Ashanthi DeSilva became the first gene therapy patient. SCID-X1 trials had success but also caused leukemia in some patients due to the retroviral vector integrating near an oncogene. Newer vectors (lentiviruses, AAV) are safer. Despite setbacks, gene therapy has cured patients with ADA-SCID, Leber's congenital amaurosis (a form of blindness), spinal muscular atrophy (SMA), and beta-thalassemia. The gene-editing tool CRISPR-Cas9 is the newest frontier — it can precisely cut and repair DNA at specific locations. RNA interference (RNAi) is a natural mechanism for silencing genes. Small RNAs (siRNA or miRNA) bind to complementary mRNA and block translation or trigger degradation. Scientists can design siRNAs to silence disease-causing genes. RNAi is also used to create pest-resistant plants — the plant is engineered to produce dsRNA that targets an essential insect gene, and when the insect eats the plant, its gene is silenced. This is a different approach from Bt toxins. Molecular diagnostics detect diseases at the molecular level, often before symptoms appear. PCR can amplify pathogen DNA from tiny samples — used to detect HIV, hepatitis B, tuberculosis, and genetic disorders. ELISA uses antibodies to detect antigens or antibodies in blood — the standard test for HIV screening. Both methods are rapid, sensitive, and specific. DNA microarrays (gene chips) can test for thousands of genetic variations simultaneously. The ethical debate around biotechnology is intense. Should we patent genes? Can we edit human embryos (germline editing)? What are the environmental risks of GM crops? Should companies own genetically modified seeds? India allows Bt cotton but has banned Bt brinjal. Different countries have different regulations. Biopiracy — using traditional knowledge or biological resources without compensation — is a concern for developing countries. The Nagoya Protocol addresses access and benefit-sharing. As the science advances, society must grapple with these questions.